Zimmer Biomet (ZBH) PT Raised to $135 at Truist Securities
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $99.50 --0%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 16
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 16
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $135.00 (from $133.00) while maintaining a Hold rating.
You May Also Be Interested In
- Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
- Ultragenyx Pharma (RARE) PT Lowered to $18 at Wells Fargo
- Broadcom Limited (AVGO) PT Raised to $475 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
